Breast Cancer Clinical Trials in Boston

Showing 241-260 of 509 trials

Losartan in Prevention of Radiation-Induced Heart Failure

NCT05607017

This study is being done to see if losartan affects the chances of developing radiation-induced heart failure in patients who are receiving radiation therapy as part of standard of care treatment for breast cancer. The interventions involved in this study are: * Losartan * Radiation Therapy (standard of care)

Breast CancerMyocardial FibrosisRadiation-Induced Fibrosis

Massachusetts General Hospital10 participantsStarted Jan 2024

Boston, Massachusetts, United States

TERMINATEDNA< 1 mile

A Breast Cancer Treatment Decision Aid for Women Aged 70 and Older

NCT02823262

The purpose of this research study is to evaluate a decision aid to help women aged 70 and older decide on treatment for their breast cancer.

Breast CancerEstrogen Receptor Positive Breast CancerNode-negative Breast Cancer+1 more

Beth Israel Deaconess Medical Center65 participantsStarted Jul 2016

Boston, Massachusetts, United States • Boston, Massachusetts, United States

TERMINATEDPhase 1< 1 mile

A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies

NCT04244552

ATRC-101-A01 is a Phase 1b, open-label dose escalation and expansion trial of ATRC-101, an engineered fully human immunoglobulin G, subclass 1 (IgG1) antibody derived from a naturally occurring human antibody. The safety, tolerability, PK, and biological activity of ATRC-101 will be characterized when administered every two weeks (Q2W) or every 3 weeks (Q3W) as a monotherapy or in combination with other anticancer agents.

Breast CancerColorectal CancerOvarian Cancer+13 more

Atreca, Inc.87 participantsStarted Feb 2020

Phoenix, Arizona, United States • Tucson, Arizona, United States • Duarte, California, United States +16 more locations

Losartan in Prevention of Radiation-Induced Heart Failure

A Breast Cancer Treatment Decision Aid for Women Aged 70 and Older

A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies

Breast Cancer Trials in Other Cities

A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms

Breast Cancer Risk Assessment in Women Aged 40-49

A Study of a New Drug Combination, Copanlisib and Fulvestrant, in Advanced Breast Cancer

Investigation of Novel Surgical Imaging for Tumor Excision

A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer

Breast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer

Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC

A Study to Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast Cancer

Development of a Questionnaire to Evaluate Patient Expectations for Breast Reconstruction in Women With Breast Cancer or Other Conditions

A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours

Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer

Radiation Therapy in Treating Women Who Have Undergone Surgery for Early-Stage Invasive Breast Cancer

A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer.

SYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer

A Study Assessing the Safety and Effectiveness of IC2000 and SPY Fluorescence Imaging Systems (SPY-PHI) in the Visualization of Lymphatic Vessels and Identification of Lymph Nodes During Sentinel Lymph Node Biopsy in Subjects With Breast Cancer

A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer

Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors

Other Conditions in Boston